News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer
Kohei Shitara/X
Feb 1, 2025, 07:13

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared an article on X he and his colleagues authored:

“Pleased to share P2 results of futibatinib for FGFR2-amplified gastric cancer: ORR 17.9%. Shows some activity but underscores need for better options. Eagerly awaiting P3 chemo + bemarituzumab data.”

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications

Authors: Taroh Satoh et al.

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

cancer Hidekazu Hirano Jaffer Ajani Jill Kremer Joon Oh Park Kazunori Honda Keun-Wook Lee Kohei shitara Lucia Nogova Mark Mina Mei Liu Min-Hee Ryu Nanae Hangai OncoDaily Oncology Philippe Barthélémy Sun Young Rha Taroh Satoh Toshihiko Doi
Special Coverage
Science
Apr 2, 2025, 10:53
Diego A. Díaz García: Cross-priming is key in cancer immunotherapy
Science
Apr 2, 2025, 10:29
Bishal Gyawali: Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers
Blog
Apr 2, 2025, 10:15
IMF Regional Community Workshop to learn all about MM - International Myeloma Foundation
Blog
Apr 2, 2025, 10:10
Ready to coordinate Advisory Board in Basilicata to improve oncology research - Sbarro Health Research Organization
Blog
Apr 2, 2025, 10:07
Teresa Amaral: Discussing neoadjuvant therapy in skin cancer at the 27th International Dermatology Meeting
Blog
Apr 2, 2025, 10:05
Wafaa M Rashed: Personalized HIV Treatment in Africa
Career
Apr 2, 2025, 10:01
Karen Knudsen: I’ve taken the helm of Parker Institute for Cancer Immunotherapy (PICI) as CEO
Blog
Apr 2, 2025, 09:58
John F. Kurland presented about immuno-oncology therapies at the IO360 Summit
Blog
Apr 2, 2025, 09:54
ACC 2025 Clinical Trials to Watch with Deepak Bhatt - Mount Sinai Department of Medicine
Blog
Apr 2, 2025, 09:46
Orouba Almilaji: NATCAN - improving the quality of National Health Service cancer care in England and Wales
Blog
Apr 2, 2025, 09:45
Susanna Fletcher Greer: The V Foundation grantee Stefani Thomas and her team explored PDX models in ovarian cancer
Blog
Apr 2, 2025, 09:30
Yan Leyfman: Ammonia - A Hidden Obstacle in Cancer Immunotherapy